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Abstract 
The aim of the research was to evaluate a
heavy metal, cadmium (Cd), which was used
to produce alterations in human breast cancer
cell line MCF-7. Moreover, we analyzed both
immunohistochemical  and  ultrastructural
alterations induced by the antineoplastic drug,
5-fluorouracil (5-FU), after exposure to differ-
ent concentrations of cd. Also, we compared
the effects of these compounds on actin and
tubulin cytoskeleton proteins. Under ultrami-
croscopic  observation,  control  cells  looked
polymorphous with filopodia. In cells already
treated with small concentrations of Cd, after
brief  times  of  incubation,  we  observed  an
intense metabolic activity with larger, clearer,
and elongated mitochondria characterized by
thin and numerous dilated cristae. 5-FU-treat-
ed cells showed cytotoxicity signs with pres-
ence of pore-like alterations in the cell mem-
brane and evident degeneration of cytoplasm
and cell nuclei. The addition of 5-FU (1.5 mM)
to the cells treated with Cd (5 mM-20 mM) did
not induce significant ultrastructural changes
in comparison with cells treated only with Cd.
In  Cd+5FU-treated  cells  mitochondria  with
globular aspect and regular cristae indicated
the active metabolic state. In cells treated only
with Cd we observed alterations in actin distri-
bution, while tubulin branched out throughout
the  cytoplasm.  With  the  association  of
Cd+5FU, we observed less morphological alter-
ations in both tubulin and actin cytoskeleton
proteins.  Although  the  mechanism  remains
unknown at present, our findings suggest that
Cd  prevents  the  cytotoxic  effect  of  5-FU  on
breast cancer cells. These preliminary results
could have an important clinical application in
patients with breast cancer.
Introduction
Cadmium (Cd) is one of the most toxic tran-
sition metals associated with air and water pol-
lution,  as  well  as  cigarette  smoking.  The
increase of industrialization and human activ-
ities have led to a greater use of metals, and,
as  a  result;  growing  ecodispersion  which
involves  considerable  economic  and  social
consequences.  It  is  dangerous  for  human
health. The absorption in the human organism
occurs  mainly  through  inhalation,  ingestion
and cutaneous contact. Cd has a long biological
half-time; its values have been seen ranging
from 15 to 40 years with an average around the
20-25 years. It is mainly accumulated in liver
and kidneys. 
Cd is considered to be one of the most dan-
gerous  metals,  especially  for  human  health,
due  to  its  teratogenic  and  carcinogenic
effects.1 Indeed, there is increasing evidence
demonstrating the, in vivo and in vitro, car-
cinogenicity of Cd, in both human and experi-
mental animal models.2,3 The heavy metal Cd
has been described to possess estrogenin-like
activity, as an endocrine disruptor.4 Moreover,
in some countries it has been used in the past,
and is still now, as a contaminant in pesticides
and  in  fungicides.  Unlike  the  inhalation  of
tobacco smoke5 representing the main source
of non-occupationally exposed adult subjects,6,7
the  metal  is  vaporized  during  combustion.
Nevertheless, the main cause of exposure to
Cd is through food ingestion.8,9 For example,
the  highest  Cd  concentrations,  compared  to
other foods,  are seen in sea food (molluscs),
and kidney and liver of mammals.10-12
The International Agency for Research on
Cancer (IARC) has classified Cd as a category
1 carcinogenic substance.2,13 Thus, the metal
could induce liver cancer, hematopoietic cells
neoplasm, bladder and stomach cancers.14 It is
also believed that Cd may have a role in the
origin of pancreatic carcinoma.2
Breast cancer is the most prevalent cancer
among women in many industrialized coun-
tries.3,15-18 The MCF-7 human breast cancer cell
line has been used as an excellent experimen-
tal model19,20to improve the efficiency of differ-
ent therapies before they are used on patients.
The MCF-7 cell line is a useful cell line that can
be used in many cancer researches and it is
also an estrogen receptor-negative.4,21The case
of glandular epithelial cells is important in the
estrogen hormones study and in the parallel
study of the cadmium-estrogens relationship
due to the ability of Cd to mimic the effects of
estrogen  receptors  tricking  the  cell  mem-
brane.21,22
The fluoropyrimidines, especially the 5-fluo-
rouracil (5-FU), are antimetabolite inhibitors
of  de  novo purine  and  pyrimidines  synthe-
ses.23,24 5-FU plays an important role in stan-
dard  chemotherapy  protocols  for  a  range  of
solid tumors, including breast and colorectal
cancers.20,21 Considering the carcinogenic and
mutagenic effects of Cd on healthy living cells,
it  seems  beneficial  to  use  a  cancer  cellular
line, such as MCF-7.3 It is particularly resistant
to harmful solicitations of toxic metals, which
provoke  alterations  to  both  cytoplasmic
organelles and cytoskeleton proteins of differ-
ent  cellular  lines.24-26 We  investigated  the
potential antagonists effects of the  antineo-
plastic  drug  5-FU,  using  scanning  electron
microscopy  (SEM),  transmission  electron
microscopy (TEM) and immunofluorescence.
The study of the modifications of cytoskeleton
proteins is a parameter particularly indicative
of the cellular and apoptotic cycle of the cellu-
lar lines. Cytoskeleton has been shown to be
involved in the traffic of a number of mem-
brane proteins. The effects of 5-FU were stud-
ied on MCF-7 cultured cells exposed to differ-
ent concentrations of Cd, and, then, we evalu-
ated  the  resulting  morphological  alterations,
even at the ultrastructural level. Moreover, in
order to clarify the mechanism of both Cd and
5-FU  activities,  we  compared  the  effects  of
these  elements  on  actin  and  tubulin,  two
cytoskeleton proteins,  responsible not only for
the intracellular transport of vesicles  and cell
organelles, but for their positioning and cellu-
lar integrity as well.  
Materials and Methods
Cell culture
Human breast cancer MCF-7 cells were cul-
tivated in Dulbecco’s Modified Eagle’s Medium
(DMEM) (Gibco) supplemented with 10% of
fetal bovine serum (FBS) (Gibco), 2.0 mmol/L
glutamine,  100  U/mL  penicillin,  and  100
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mg/mL streptomycin. Cells were grown at 37°C
in  an  atmosphere  containing  5%  CO2,  then
expanded for several days to become confluent
in T75 flasks for cellular culture. They were
then treated with Trypsin-EDTA (Invitrogen)
and plated in a 24-well plate for immunohisto-
chemistry  and  SEM  preparation,  and  in  T75
bottles for TEM preparation. 
Drugs and drug treatments
Cells were treated with 5-FU and Cadmium
Chloride  (CdCl2),  purchased  from  Sigma-
Aldrich. The drugs were dissolved in DMSO or
water  and  stored  at  -20°C.  For  each  experi-
ment, the stock solutions were further diluted
to obtain the desired concentrations. The final
solvent  concentration  in  cell  culture  was  =
0.1%  v/v  of  DMSO,  a  concentration  without
effect on cell replication. Parallel cultures of
cells in medium with DMSO were used as con-
trols. 
Cytotoxicity assays in vitro
The effect of anticancer drugs on cell viability
was assessed using the sulforhodamine-B colori-
metric assay. Aliquots of MCF-7 cells suspension
(1×103 cells/well)  were  seeded  onto  24-well
plates and incubated for 24 h. The cells were then
treated with different concentrations of drugs in
the culture medium. Three days later, the wells
were aspirated, fresh medium and treatment was
added, and the cells were maintained for an addi-
tional  three  days.27 Thereafter,  the  cells  were
processed  as  described  previously,  using  a
Titertek Multiscan apparatus (Flow, Irvine, CA,
USA) at 492 nm. We evaluated linearity of the
SRB assay with cell number for each cell line
before each cell growth experiment. The IC50 val-
ues were calculated from semi logarithmic dose-
response curves by linear interpolation. All of the
experiments were plated in triplicate wells and
were carried out at least twice. For each of the
experiments  we  used  different  concentrations
and at different time points (Table 1).
Electron microscopy 
MCF-7 cells were treated with Cd (5 mM, 20
mM, 40 mM) and 5-FU (1.5 mM) at different time
points (24 h, 48 h) (Table 1). The cells pellet,  to
be observed by TEM, were fixed in a 2% glu-
taraldehyde solution in a 0.1 M cacodylate buffer
(1 h), and washed  three times, 15 min each, in
the same buffer. Cells post-fixation was done
with 1% osmium tetroxide (OsO4) (1 h), washed
again  in  buffer  and  distilled  water,  and  then
embedded  in  1.5%  low-melting-point  agarose.
Small blocks (1 mm x 1 mm) were cut out after
the agarose had solidified. After dehydration by
graded ethanol, the blocks were embedded in
Spurr’s low-viscosity resin. After ultra thin sec-
tions were prepared by the LKB-8800 ultratome,
with 4% uranyl acetate and lead citrate, the sam-
ples  were  stained.  Photographic  images  were
examined using a Zeiss 902 electron microscope
at 80 kV. Culture cells, grown on circular cover-
slip, were fixed in 2.5% glutaraldehyde solution
in phosphate buffer saline (PBS) for 90 min,
then washed three times for 5 min each in  PBS,
and post-fixed in 1% OsO4 for 2 h. After three
washes, 5 min each in PBS, the samples were
dehydrated  through  graded  alcohol  solutions,
air-dried  with  hexamethyldisilazane28,29 (10
min), examined under an ESEM (environmental
scanning  electron  microscope),  and  pho-
tographed in low vacuum using both SEM FEI
Inspect S and Quanta 200.
Immunohistochemistry
Confluent  cells  were  treated  with  trypsin-
EDTA (Sigma-Aldrich) and plated on round cov-
erslips (12 mm) in 24-well culture plates. We
incubated them for 24 and 48 h, after which an
additional concentration of Cd (5 mM, 20 mM, 40
mM) and 5-FU (1.5 mM) (Table 1) was added.
After fixation with formaldehyde 4%, membrane
permeabilization with Triton 0.2%, and satura-
tion with BSA 1%, the cells were incubated for 
1  h  with  a  monoclonal  anti-tubulin  (Sigma-
Aldrich),  and  then  conjugated  with  Ab  anti-
mouse FITC (Sigma-Aldrich). In order to study
actin, we incubated cells with TRITC-phalloidin
conjugated  (Sigma-Aldrich).  The  nuclei  were
observed  by  DAPI,  and  finally  the  coverslips,
mounted by Mowiol on an object slide were stud-
ied  using  fluorescence  microscopy  Olympus
BX61  (objective  UplanApo  100x/1,35oil/iris,
objective UplanApo 40x/0, 75) with digital B/W
camera FViewII (Soft Imaging System), and ana-
lyzed  by  Cell  software  (CELL^P  ver  1.20  Soft
Imaging System, Olympus Soft Imaging Solution
GmbH, Munster, Germany). 
Results
Cytotoxicity asssay
To evaluate the cytotoxicity of Cd and 5-FU
human breast cancer cell line MCF-7 we used
the SRB staining method. IC50values, defined as
the drug concentration resulting in 50% loss of
cell viability relative to the untreated cells, were
determined for the compound. The IC50 value
for Cd was 5±0.25 mM and for 5-FU 1.5±0.3 mM.
Electron microscopy 
TEM  analysis  showed  that  control  MCF-7
breast cancer cells were polymorphous. The cen-
trally placed nucleus showed indentation, usual-
ly contained one or two prominent nucleoli, and
possessed an evident nuclear membrane. The
cytoplasmic  organelles  appeared  well  defined
and possessed a large number of mitochondria
with  globular  aspect  and  lamellar  cristae.
Furthermore, the cell surface was characterized
by a high microvillus density. SEM showed a
variety of elongated and polygonal shaped cells
with numerous slender and thick cytoplasmic
projections and an increased number of filopo-
dia (Figure 1 a,b,c).
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Table 1. Time and concentrations of exper-
imental conditions.
Concentrations Time point
Ctrl - 24h, 48h
Cd 5 µM / 20 µM/40 µM  24h, 48h
5-FU 1.5 µM    24h, 48h
Cd+5-FU Cd 5 µM/Cd 20 µM+  24h, 48h
5-FU 1.5 µM
Figure 1. a) TEM 3000X, MCF-7 control; the cells, with polymorphous aspect, present
numerous globular mitochondria with lamellar cristae (big arrow) and microvilli (thin
arrow); b) SEM 3000X, MCF-7 control; the cells with polymorphous cytoplasm, are rich
in microvilli  (big arrow) and long filopodia (thin arrow);  c) detail of b), MCF-7 control,
the filopodia (thin arrow) are evident. Scale bar: 5 µm. [European Journal of Histochemistry 2012; 56:e1] [page 3]
Cadmium
Cd-treated cells at low concentration (5 mM)
and  for  short  times  of  incubation  (24  h)
showed an intense metabolic activity with larg-
er, clearer and globular mitochondria charac-
terized by thin and numerous dilated cristae.
Additionally,  a  large  number  of  glycogen
deposits in clusters were found. The nuclei of
all  the  cells  contained  completely  dispersed
chromatin and one or two large nucleoli, which
were peripherally located (Figure 2a). The sur-
face of Cd-treated cells at low concentrations
observed under SEM looked similar to the sur-
face of the control cells, displaying short and
abundant  microvilli  and  infrequent  blebs
(Figure 2b). At high concentrations of Cd (20
mM) and 24 h of treatment, the nuclei became
very evident, and moved sideways in the cellu-
lar membrane. Numerous cytoplasmic vesicles
were seen, including abundant mitochondria
with lamellar cristae sometimes altered. The
vesicles were close to the plasmalemma and
showed  signs  of  exocytosis.  We  observed  a
reduction  of  the  superficial  filopodia,
although,  under  extreme  conditions  (Cd  40
mM,  48  h),  they  increased  significantly  in
number  and  showed  an  increase  of  cellular
death. Furthermore, numerous blebs of differ-
ent sizes were noticed and cells became more
rounded and less attached to the dish.
5-FU
5-FU  induced  cytotoxicity  in  MCF-7  cells
showed, cytoplasmic alterations, an increased
number of distended vesicles appearing, and
swollen mitochondria with partial crista loss.
Components  of  cell  nuclei  displayed  evident
signs of degeneration. There was an absence
of nucleoli, and the chromatin condensed into
dense granules located near the nuclear mem-
brane (Figure 2c). SEM analyses showed that
5-FU-treated  cells  had  lengthened,  became
more  irregular,  and  there  were  numerous
intercellular spaces. However, the most strik-
ing feature was the pore-like alterations in the
cell  membrane,  which  were  absent  in  both
parental MCF-7 cells and Cd-treated cells. Also,
we  observed  cells  more  rounded  and  less
attached to the dish (Figure 2d).
Cadmium plus 5-FU
The addition of 5-FU to cells treated with Cd
(5-20  mM)  did  not  induce  significant  ultra-
structural changes compared with cells treated
only with Cd. In cells treated with Cd 40 mM,
the cellular death increased. In Cd+5FU-treat-
ed cells, numerous mitochondria with globular
aspect and regular cristae were present. The
nucleus was regular in shape with dispersed
chromatin  and  one  or  two  nucleoli.  These
observations indicate a cell system in an active
metabolic state. SEM analyses showed flat cells
with short filopodia (Figure 2 e,f), that after 48
h of treatment were made shorter and tended
to disappear.
Immunohistochemistry
In  control  cells  both  tubulin  and  actin
appeared distributed in the cytoplasm showing
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Figure 2. TEM, a)  3000X, MCF-7+Cd 5
µM-24h  the cellular nucleus is indented
with dispersed chromatin and a peripheral
nucleolus (big arrow), in the cytoplasm are
evident  numerous  mitochondria  with
dilated  cristae  (thin  arrow);  b)    SEM
3000X,  MCF-7+Cd  5  µM-24h;  some
microvilli  exhibit  some  prolongations  of
great  dimensions  (big  arrow);  c)  TEM
3000X, MCF-7+5-Fu 1.5 µM-24h; in the
cytoplasm are evident numerous  clear vesi-
cles (*), swollen mitochondria with a num-
ber of condensed cristae (big arrow); in the
nucleus there are little areas of heterochro-
matin close to the membrane (thin arrow);
d) SEM 3000X, MCF-7+5-Fu 1.5µM-24h;
the  cells  show  alterations    on  the  mem-
brane  (big  arrow);  zones  of  detachment
from  the  coverslip  (thin  arrow)  also  are
seen;  e)  TEM  3000X,  MCF-7+Cd  20
µM+5-Fu 1.5 µM-24h; the cell shows an
indented  nucleus  with  two  nucleoli  (big
arrow)  and  mitochondria  with  globular
aspect (thin arrow); f) SEM 3000X, MCF-
7+Cd 20 µM+5-Fu 1.5 µM-24h; the cells,
with fairly regular contours, present short
and thin prolongations (big arrow). Scale
bar: 5 µm.
Figure 3. MCF-7 100X: a,b,c)  control (tubulin-FITC, phalloidin-TRITC, Merge) tubu-
lin and actin are organized in filamentous structures and are regularly distributed in the
cytoplasm; d,e,f)  Cd 5 µM-24h (FITC, TRITC, Merge); g,h,i)  Cd 20 µM-48h (FITC,
TRITC, Merge); tubulin is mainly distributed in the nucleus and cytoplasm; actin is con-
stituted by big bundles of filaments and smeared patche. Scale bar: 5 µm.[page 4] [European Journal of Histochemistry 2012; 56:e1]
a well-organized filamentous structure (Figure
3 a,b,c). 
Cadmium
In cells treated with Cd (5 mM and 20 mM)
for  24  h,  tubulin  did  not  undergo  structural
changes; it remained quite distributed in the
nuclear  and  cytoplasmatic  zone  (Figure  3
d,e,f,g,h,i). After treatment with Cd the fine
architecture  of  actin  filaments  appeared
changed, consisting of large bundles of fila-
ments  which,  in  some  points,  thickened  to
form smeared patches. This finding was quite
similar to that observed after incubation with
Cd 5 mM (Figure 3 d,e,f) and became more pro-
nounced with Cd 20 mM. High concentrations
of Cd induced a strong, evident, actin expres-
sion  in  the  plasmatic  membrane.  Tubulin,
especially in MCF-7 cells treated with Cd 20
mM, appeared with an intense perinuclear and
compact  fluorescence  from  which  separate
arrays  of  filaments  departed,  branching  out
throughout  the  cytoplasm  (Figure  3  g,h,i).
Cells treated with Cd 40 mM, as already said,
showed a cellular death increase.
5-FU
In  5-FU-treated  cells  actin  appeared  less
organized and filamentous. Tubulin filaments
showed a regular halo of labeling around the
nuclear membrane that did not spread into the
cytoplasm. The times of incubation of 24 and
48  h  did  not  show  substantial  differences
(Figure 4 a,b).
Cadmium plus 5-FU 
In Cd (5 mM-20 mM) +5-FU-treated cells for
24 h actin expression was less filamentous com-
pared to parental non-treated cells; neverthe-
less, the distribution was clearly better than in
the  Cd-only-treated  cells.  Tubulin  showed
expression and distribution patterns similar to
those  seen  in  control  and  Cd-treated  cells
(Figure 4 d,e,f). In cells treated for 48 h with Cd
(5 mM - 20 mM) +5FU, actin was progressively
breaking, whereas tubulin maintained a stable
and  ordered  structure  (Figure  4  g,h,i).
Therefore,  the  association  Cd+5-FU  induced
less alterations in both actin and tubulin pro-
teins. Under extreme conditions (Cd 40 mM, 48
h), the addition of 5-FU did not significantly
modify the cellular disorder observed with only
Cd. 
Discussion 
Cadmium is a heavy metal present in the
environment with proven carcinogenic effects
on several organs including lung, liver, kidneys
and  prostate,  among  others.2 The  damaging
effects in the cytoskeleton bring about a com-
plete disappearance of microtubules30 and the
disruption of the filamentous actin protein.31
The action of Cd on the proliferation of MCF-7
breast cancer cell line has been proved.32 Yet,
5-FU is an antitumor drug, with an important
role in standard chemotherapy protocols, for a
range of solid tumors including breast cancer
and colorectal cancers.33
Our results demonstrated that in the cells
treated only with Cd, there are ultrastructural
changes in MCF-7 cells, including the appear-
ance of secretive vacuoles in the cellular cyto-
plasm, probably lysosomes. Cells can produce
these vesicles as a response to the exposure to
Cd. The increase of lysosomes after exposure
of Cd is known as a mechanism of sequestra-
tion and excretion of substances taken up by
cells  from  the  environment.14 Moreover,  Cd
induced mitochondrial swelling with a dense
matrix  in  comparison  to  control  non-treated
MCF-7  cells,  which  presented  globular  mito-
chondrial  with  regular  lamellar  cristae.  In
breast  cancer  cells  it  can  be  supposed  that,
besides  the  implication  of  mitochondria  in
phenomena of oxidative stress;34 the morpho-
logical alterations of membranes being a pos-
sible consequence of variations in transcrip-
tion  and,  consequently,  transduction  to  the
block of metallothionein.35
Moreover, in Cd-treated cells, nuclei were
usually moved toward the cellular membrane
and a large number of vesicles and organelles
were present from the opposite part of the cell.
Actin filaments were arranged as big bundles
in the cytoplasmic membrane, while the tubu-
lin branched out throughout the cytoplasm. All
of  this  would  explain  the  perimembranous
position of the nucleus.26 It has been demon-
strated that Cd increases proliferation in MCF-
7 breast cancer cells and disrupt the normal
cell homeostasis triggering signals otherwise
switched off.36
5-FU-treated  cells  displayed  characteristic
signs of degeneration in both cytoplasm and
nucleus such as the lack of membrane integri-
ty  and  the  appearance  of  exocytotic  bodies.
Moreover, an increased rate of spherical and
non-adherent cells was present after treatment
with a high dose of 5-FU. These effects indi-
cate  the  anticancer  properties  of  the
antimetabolite 5-FU, which acts hindering the
cellular growth and increasing the secretion of
vesicles of lysosomal nature.37 Combined treat-
ment of Cd and 5-FU did not alter ultrastructur-
al components showing similar characteristics
to MCF-7 cells, which were only treated with
Cd, independently of 5-FU dose. We observed
that the tubulin aspect is comparable to control
non-treated cells and that the actin presents a
non- filamentous organization like in Cd-treat-
ed  cells.  These  results  suggest  that  Cd  pre-
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Figure 4. MCF-7 100X: a,b,c) 5-FU 1.5µM-48h (FITC, TRITC, Merge) actin is less
organized and filamentous then Ctrl, tubulin shows a regular halo of labelling around the
nuclear membrane; d,e,f)  Cd 5µM + 5-FU 1.5µM-24h (FITC, TRITC, Merge); actin is
less filamentous, although its distribution looks better improved than in the Cd-only-
treated cells; tubulin has a distribution patterns similar to that of control and Cd-treated
cells; g,h,i)  Cd 20µM+5-FU 1.5µM-48h (FITC, TRITC, Merge) actin is progressively
breaking, whereas tubulin maintains a stable and ordered structure. Scale bar: 5 µm.[European Journal of Histochemistry 2012; 56:e1] [page 5]
vents  the  anticancer  effects  of  5-FU.  This
blockage acts preventing the formation of lyso-
somes in the cytoplasm, that is in relationship
with oxidized stress at mitochondrial level.35,38
With the combination Cd+5FU there are few
and small number of lysosomal vesicles. 
In  conclusion,  in  the  present  study  we
demonstrated the importance of the interac-
tion between the heavy environmental metal
Cadmium, and the antitumor drug 5-FU from a
morphological  point  of  view.  Although  the
mechanism remains unknown at present, our
findings suggest that Cd prevents the cytotox-
ic effect of 5-FU on breast cancer cells. Further
research is required to fully analyze correla-
tions between our morphological results and
the bimolecular aspects involved in this phe-
nomenon.
Our results suggest the  study of patients
exposed to environmental pollution, including
cigarette smoke, and treated with chemothera-
py with  the determination of cadmium levels
in breast cancer patients with negative estro-
gen receptor before 5-FU treatment, in order to
highlight  a  possible  interaction  in  vivo
between Cd and anticancer drugs. 
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